We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.

  • revolutionizing precision medicine

Management team

Paul van de Wiel

Chief Executive Officer

Sigi Neerken

Chief Business Officer

Eveline den Biezen

Chief Technology Officer

Anke Pierik

Chief Operating Officer